|
[1] Editorial Board of Chinese Journal of Pancreatology.Consensus statements on autoimmune pancreatitis in China (Draft) (2012, Shanghai) [J].Chin J Pancreatol, 2012, 12 (6) :410-418. (in Chinese) 《中华胰腺病杂志》编委会.我国自身免疫性胰腺炎共识意见 (草案2012, 上海) [J].中华胰腺病杂志, 2012, 12 (6) :410-418.
|
|
[2]SARLES H, SARLES JC, MURATORE R, et al.Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease?[J].Am J Dig Dis, 1961, 6:688-698.
|
|
[3]TOKI F, KOUZU T, OI I, et al.An unusual type of chronic pancreatitis showing diffuse irregular narrowing of the entire main pancreatic duct on ERCP.A report of four cases[J].Endoscopy, 1992, 24:640.
|
|
[4]YOSHIDA K, TOKI F, TAKEUCHI T, et al.Chronic pancreatitis caused by an autoimmune abnormality.Proposal of the concept of autoimmune pancreatitis[J].Dig Dis Sci, 1995, 40 (7) :1561-1568.
|
|
[5]HAMANO H, KAWA S, HORIUCHI A, et al.High serum Ig G4 concentrations in patients with sclerosing pancreatitis[J].N Engl J Med, 2001, 344 (10) :732-738.
|
|
[6]COMINGS DE, SKUBI KB, VAN EYES J, et al.Familial multifocal fibrosclerosis.Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease[J].Ann Intern Med, 1967, 66 (5) :884-892.
|
|
[7]UMEHARA H, OKAZAKI K, MASAKI Y, et al.Comprehensive diagnostic criteria for Ig G4-related disease (Ig G4-RD) , 2011[J].Mod Rheumatol, 2012, 22 (1) :21-30.
|
|
[8]OKAZAKI K, UCHIDA K.Autoimmune pancreatitis:The past, present, and future[J].Pancreas, 2015, 44 (7) :1006-1016.
|
|
[9]HAYAKAWA T, KOIZUMI M, ATOMI Y, et al.Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society[J].J Jpn Pancr Soc, 2002, 17 (6) :585-587.
|
|
[10]OTSUKI M, CHUNG JB, OKAZAKI K, et al.Asian diagnostic criteria for autoimmune pancreatitis:Consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis[J].J Gastroenterol, 2008, 43 (6) :403-408.
|
|
[11]KIM KP, KIM MH, KIM JC, et al.Diagnostic criteria for autoimmune chronic pancreatitis revisited[J].Word J Gastroenterol, 2006, 12 (16) :2487-2496.
|
|
[12]LYU H, QIAN JM.Discussion of different sets of diagnostic criteria in autoimmune pancreatitis[J].Chin J Gastroenterol, 2009, 14 (1) :4-7. (in Chinese) 吕红, 钱家鸣.自身免疫性胰腺炎不同诊断标准的探讨[J].胃肠病学, 2009, 14 (1) :4-7.
|
|
[13]CARRUTHERS MN, STONE JH, DESHPANDE V, et al.Development of an Ig G4-RD responder index[J].Int J Rheumatol, 2012, 2012:259408.
|
|
[14]KHOSROSHAHI A, WALLACE ZS, CROWE JL, et al.International consensus guidance statement on the management and treatment of Ig G4-related disease[J].Arthritis Rheumatol, 2015, 67 (7) :1688-1699.
|
|
[15]VASAITIS L.Ig G4-related disease:A relatively new concept for clinicians[J].European Eur J Intern Med, 2016, 27:1-9.
|
|
[16]ZHANG L, CHARI S, SMYRK TC, et al.Autoimmune pancreatitis (AIP) type 1 and type 2:An international consensus study on histopathologic diagnostic criteria[J].Pancreas, 2011, 40 (8) :1172-1179.
|
|
[17]KAMISAWA T, OKAZAKI K, KAWA S, et al.Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013III.Treatment and prognosis of autoimmune pancreatitis[J].J Gastroenterol, 2014, 49 (6) :961-970.
|
|
[18]KUBOTA K, KAMISAWA T, OKAZAKI K, et al.Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis:A long-term Japanese multicenter analysis of 510 patients[J].J Gastroenterol, 2017, 52 (8) :955-964.
|
|
[19]SMIT W, BARNES E.The emerging mysteries of Ig G4-related disease[J].Clin Med (Lond) , 2014, 14 (Suppl 6) :s56-s60.
|
|
[20]SHIMIZU S, NAITOH I, NAKAZAWA T, et al.Correlation between long-term outcome and steroid therapy in type 1 autoimmune pancreatitis:Relapse, malignancy and side effect of steroid[J].Scand J Gastroenterol, 2015, 50 (11) :1411-1418.
|
|
[21]PIERINGER H, PARZER I, WOHRER A, et al.Ig G4-related disease:An orphan disease with many faces[J].Orphanet J Rare Dis, 2014, 9:110.
|
|
[22] de PRETIS N, AMODIO A, BERNARDONI L, et al.Azathioprine maintenance therapy to prevent relapses in autoimmune pancreatitis[J].Clin Transl Gastroenterol, 2017, 8 (4) :e90.
|
|
[23]SELEZNIK G, GRAF R.Alternatives to steroids?!Beneficial effects of immunosuppressant drugs in autoimmune pancreatitis[J].Gut, 2014, 63 (3) :376-377.
|
|
[24]BUECHTER M, KLEIN CG, KLOETERS C, et al.Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with Ig G4-associated cholangitis[J].Z Gastroenterol, 2014, 52 (6) :564-568.
|
|
[25] SCHWAIGER T, van den BRANDT C, FITZNER B, et al.Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment[J].Gut, 2014, 63 (3) :494-505.
|
|
[26]HART PA, TOPAZIAN MD, WITZIG TE, et al.Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab:The Mayo Clinic experience[J].Gut, 2013, 62 (11) :1607-1615.
|
|
[27]CARRUTHERS MN, TOPAZIAN MD, KHOSROSHAHI A, et al.Rituximab for Ig G4-related disease:A prospective, open-label trial[J].Ann Rheum Dis, 2015, 74 (6) :1171-1177.
|
|
[28]WALLACE ZS, STONE JH.An update on Ig G4-related disease[J].Curr Opin Rheumatol, 2015, 27 (1) :83-90.
|
|
[29]YAMAMOTO M, NOJIMA M, TAKAHASHI H, et al.Identification of relapse predictors in Ig G4-related disease using multivariate analysis of clinical data at the first visit and initial treatmen[J].Rheumatology, 2015, 54 (1) :45-49.
|
|
[30]LIN W, ZHANG P, CHEN H, et al.Circulating plasmablasts/plasma cells:A potential biomarker for Ig G4-related disease[J].Arthritis Res Ther, 2017, 19 (1) :25.
|
|
[31]LIN W, LU S, CHEN H, et al.Clinical characteristics of immunoglobulin G4-related disease:A prospective study of 118 Chinese patients[J].Rheumatology (Oxford) , 2015, 54 (11) :1982-1990.
|
|
[32]LIN W, JIN L, CHEN H, et al.B cell subsets and dysfunction of regulatory B cells in Ig G4-related diseases and primary Sjogren's syndrome:The similarities and differences[J].Arthritis Res Ther, 2014, 16 (3) :r118.
|
|
[33]CHEN Y, ZHAO JZ, FENG RE, et al.Types of organ involvement in patients with immunoglobulin G4-related disease[J].Chin Med J (Engl) , 2016, 129 (13) :1525-1532.
|
|
[34]DING H, QIAN JM, LYU H, et al.The study of efficacy and prognosis in corticosteroid treated autoimmune pancreatitis[J].Chin J Dig, 2010, 30 (10) :721-724. (in Chinese) 丁辉, 钱家鸣, 吕红, 等.自身免疫性胰腺炎激素治疗的疗效及预后研究[J].中华消化杂志, 2010, 30 (10) :721-724.
|
|
[35]LYU H, JIANG WZ, QIAN JM, et al.Clinical features of autoimmune pancreatitis:A case series of 16 patients[J].Chin J Pancreatol, 2010, 10 (3) :155-158. (in Chinese) 吕红, 蒋卫忠, 钱家鸣, 等.自身免疫性胰腺炎16例的临床分析[J].中华胰腺病杂志, 2010, 10 (3) :155-158.
|
|
[36]LAI YM, WU D, YANG H, et al.Epidemiology and clinical characteristics of type 1 autoimmune pancreatitis[J].Basic Clin Med, 2017, 37 (11) :1607-1610. (in Chinese) 赖雅敏, 吴东, 杨红, 等.1型自身免疫性胰腺炎的流行病学及临床特点[J].基础医学与临床, 2017, 37 (11) :1607-1610.
|
DownLoad: